Atazanavir/ritonavir + lamivudine/zidovudine - Mylan pharmaceuticalsAlternative Names: Ritonavir/atazanavir + zidovudine/lamivudine - Mylan pharmaceuticals
Latest Information Update: 17 Jul 2015
At a glance
- Originator Mylan Pharmaceuticals
- Class Amides; Azides; Carbamates; Dideoxynucleosides; Oligopeptides; Pyridines; Pyrimidine nucleosides; Small molecules; Thiazoles
- Mechanism of Action HIV protease inhibitors; Nucleoside reverse transcriptase inhibitors; RNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration HIV-1 infections